Adjuvant radiotherapy for FIGO 2023 stage IC endometrial carcinoma
While patients with FIGO 2023 stage IC endometrial carcinoma typically achieve favorable outcomes after adjuvant RT, malignant peritoneal cytology remains an adverse prognostic factor. In this subgroup, escalation of adjuvant therapy, such as combination chemotherapy, may be appropriate.
Authors
- Melis Gültekin (ORCID: https://orcid.org/0000-0002-1806-2619)
- Alper Kahvecioğlu (ORCID: https://orcid.org/0000-0001-8714-2383)
- Sezin Yüce Sarı (ORCID: https://orcid.org/0000-0003-2395-6868)
- Ferah Yıldız (ORCID: https://orcid.org/0000-0002-2557-8103)
- Zafer Arık (ORCID: https://orcid.org/0000-0002-0598-389X)
- Alp Usubutün (ORCID: https://orcid.org/0000-0001-9572-7875)
- Ecem Yiğit (ORCID: https://orcid.org/0000-0002-8850-4830)
- Utku Akgör (ORCID: https://orcid.org/0000-0003-1377-2651)
- Derman Başaran (ORCID: https://orcid.org/0000-0002-2689-1417)
- Nejat Özgül (ORCID: https://orcid.org/0000-0002-4257-9431)
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- Journal of Turkish Society of Obstetric and Gynecology
- Published
- 2025-12-02
- DOI
- https://doi.org/10.4274/tjod.galenos.2025.10662
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00